NCT00420485View on ClinicalTrials.gov

Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Solid Tumors
Interventions
DRUG

gimatecan

Trial Locations (12)

310

Novartis Investigative Site, Oslo

21034

Novartis Investigative Site, Dijon

28041

Novartis Investigative Site, Madrid

31052

Novartis Investigative Site, Toulouse

44805

Novartis Investigative Site, Saint-Herblain

55101

Novartis Investigative Site, Mainz

72076

Novartis Investigative Site, Tübingen

75005

Novartis Investigative Site, Paris

Unknown

Novartis Investigative Site, Vancouver

Novartis Investigative Site, Enschede

M5G 2M9

MD Anderson Cancer Center - Orlando, Toronto

DK-2100

Novartis Investigative Site, Copenhagen

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY